Dupixent scores speedy review for rhinosinusitis with nasal polyps; After transplant, third patient is HIV-free for 3 months
→ Regeneron $REGN and Sanofi’s $SNY monoclonal antibody Dupixent — already approved for eczema and asthma — is in line for another approval. The FDA has granted …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
